ZYVOX(R) shows high success rate for patients who develop MRSA surgical site infections

Surgical patients treated with Pfizer's novel antibiotic ZYVOX® (linezolid; injection, tablets, and for oral suspension) had a significantly higher rate of microbiologic success (documented or presumed eradication) than those treated with intravenous (IV) vancomycin for surgical site infections (SSIs) caused by methicillin-resistant Stap...

Continue to ZYVOX(R) shows high success rate for patients who develop MRSA surgical site infections on Medical News Today.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz